RDHL · RedHill Biopharma Ltd.
Market Cap
$4.41M
Shares
6.08M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 6-K | 2026-09-01 | — | |
| 6-K | 2026-08-31 | — | |
| 6-K | 2026-08-07 | — | |
| 6-K | 2026-08-06 | — | |
| 6-K | 2026-07-28 | — | |
| 6-K | 2026-07-01 | — | |
| 6-K | 2026-06-29 | — | |
| 6-K | 2026-06-25 | — | |
| 6-K | 2026-06-22 | — | |
| 6-K | 2026-06-22 | — | |
| 6-K | 2026-06-22 | — | |
| 6-K | 2026-06-18 | — | |
| 6-K | 2026-06-09 | — | |
| 6-K | 2026-06-08 | — | |
| 6-K | 2026-06-02 | — | |
| 6-K | 2026-05-27 | — | |
| 6-K | 2026-04-30 | — | |
| 20-F | 2026-04-27 | 2025-12-31 | |
| 6-K | 2026-04-27 | — | |
| 6-K | 2026-04-22 | — | |
| 6-K | 2026-04-14 | — | |
| 6-K | 2026-03-05 | — | |
| 6-K | 2026-02-25 | — | |
| 6-K | 2026-01-27 | — | |
| 6-K | 2026-01-22 | — | |
| 6-K | 2026-01-05 | — | |
| 6-K | 2025-12-31 | — | |
| 6-K | 2025-12-23 | — | |
| 6-K | 2025-12-15 | — | |
| 6-K | 2025-12-01 | — | |
| 6-K | 2025-11-26 | — | |
| 6-K | 2025-11-04 | — | |
| 6-K | 2025-10-22 | — | |
| 6-K | 2025-10-21 | — | |
| 6-K | 2025-10-20 | — | |
| 6-K | 2025-10-06 | — | |
| 6-K | 2025-09-29 | — | |
| 6-K/A | 2025-09-05 | 2025-06-30 | |
| 6-K | 2025-09-05 | 2025-06-30 | |
| 6-K | 2025-08-20 | — | |
| 6-K | 2025-08-18 | — | |
| 6-K | 2025-08-14 | — | |
| 6-K | 2025-07-21 | — | |
| 6-K | 2025-07-01 | — | |
| 6-K | 2025-06-25 | — | |
| 6-K | 2025-05-27 | — | |
| 6-K | 2025-05-19 | — | |
| 6-K | 2025-05-13 | — | |
| 6-K | 2025-05-05 | — | |
| 6-K | 2025-05-02 | — |
Showing 1–50 of 363 filings